Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine for Myocardial Fatty Acid Metabolism in Hemodialysis
NCT02322697Completed
- Sponsor
- Toujinkai Hospital
- Start
- Aug 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of levocarnitine in left ventricular dysfunction and disorder of myocardial fatty acid metabolism (2 arms), sponsored by Toujinkai Hospital. Primary endpoint: Changes in BMIPP summed scores of the SPECT imaging at 1 year. Started Aug 2013; status: completed.
02
Drugs
levocarnitine
03
Conditions
left ventricular dysfunctiondisorder of myocardial fatty acid metabolism
Beyond the preview
Go deeper on NCT02322697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02322697.